9.79
Dynavax Technologies Corp stock is traded at $9.79, with a volume of 1.93M.
It is up +0.94% in the last 24 hours and down -16.15% over the past month.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
See More
Previous Close:
$9.76
Open:
$9.72
24h Volume:
1.93M
Relative Volume:
0.76
Market Cap:
$1.18B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
75.31
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
+0.53%
1M Performance:
-16.15%
6M Performance:
-23.39%
1Y Performance:
-16.65%
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
DVAX
Dynavax Technologies Corp
|
9.79 | 1.18B | 260.81M | 20.48M | 22.67M | 0.13 |
![]()
HLN
Haleon Plc Adr
|
11.34 | 49.79B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
ZTS
Zoetis Inc
|
168.62 | 72.11B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
RDHL
Redhill Biopharma Ltd Adr
|
1.79 | 4.24M | 35.75M | 11.57M | -26.25M | -3.8069 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 45.01B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.77 | 19.43B | 16.54B | -1.64B | 749.00M | -1.45 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
Feb-01-24 | Initiated | Goldman | Neutral |
Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
Jan-06-22 | Resumed | Goldman | Buy |
Aug-06-21 | Initiated | Goldman | Buy |
Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
Jun-15-20 | Initiated | Evercore ISI | Outperform |
Oct-18-19 | Initiated | H.C. Wainwright | Buy |
Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
Dynavax Showcases Commercial Vaccine Pipeline at Major William Blair Conference: Key Updates Coming - Stock Titan
Quantinno Capital Management LP Raises Holdings in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Ameriprise Financial Inc. Sells 16,176 Shares of Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Dynavax Technologies Co. (NASDAQ:DVAX) Shares Purchased by Deutsche Bank AG - Defense World
Bank of America Corp DE Sells 124,301 Shares of Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Dynavax’s SWOT analysis: vaccine maker’s stock rides hepatitis B success - Investing.com
Dynavax Shareholders Urged To Back Current Board Against Deep Track's Push - Finimize
Major Dynavax Investor Deep Track (14.82% Stake) Fights ISS as Heplisav Market Share Drops to 43% - Stock Titan
ISS backs Dynavax directors in board fight with Deep Track Capital - marketscreener.com
Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees - Yahoo Finance
Dynavax Technologies Corp (DVAX) Shares Gap Down to $10.1 on May 21 - GuruFocus
Dynavax Technologies Co. (NASDAQ:DVAX) Holdings Boosted by BNP Paribas Financial Markets - Defense World
Deep Track presses for change at Dynavax amid performance concerns - Investing.com
Deep Track presses for change at Dynavax amid performance concerns By Investing.com - Investing.com Canada
Dynavax Technologies Co. (NASDAQ:DVAX) Shares Sold by The Manufacturers Life Insurance Company - Defense World
Major Shareholder Attacks Dynavax Management as Stock Hits 52-Week Low: Key Details from Scathing Letter - Stock Titan
Northern Trust Corp Has $18.62 Million Stake in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Raymond James Financial Inc. Invests $192,000 in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
SEC Form DEFA14A filed by Dynavax Technologies Corporation - Quantisnow
Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value - Yahoo Finance
Dynavax Files Investor Presentation with Shareholders - marketscreener.com
Hsbc Holdings PLC Acquires 4,859 Shares of Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
/C O R R E C T I O N -- Dynavax Technologies/ - Yahoo Finance
First Trust Advisors LP Invests $847,000 in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
William Blair Has Optimistic Outlook of DVAX Q3 Earnings - Defense World
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why - Yahoo Finance
Ratio Revelations: Dynavax Technologies Corp (DVAX)’s Financial Metrics in the Spotlight - DWinneX
Dynavax Technologies First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Dynavax Technologies (NASDAQ:DVAX) Trading Down 9.2% Following Weak Earnings - Defense World
Envestnet Asset Management Inc. Purchases 2,796 Shares of Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
StockNews.com Downgrades Dynavax Technologies (NASDAQ:DVAX) to Hold - Defense World
Dynavax Technologies (NASDAQ:DVAX) Hits New 1-Year Low Following Analyst Downgrade - Defense World
Dynavax counters Deep Track’s short-term strategy By Investing.com - Investing.com Canada
Dynavax (DVAX) Urges Support for Board Nominees Ahead of 2025 Me - GuruFocus
Dynavax Issues Statement And Mails Letter To Stockholders Emphasizing Record Financial Results And Continued Momentum - marketscreener.com
Dynavax counters Deep Track’s short-term strategy - Investing.com
Breaking Down Dynavax Technologies: 5 Analysts Share Their Views - Benzinga
Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum - Stock Titan
Dynavax Technologies Becomes Oversold (DVAX) - Nasdaq
Dynavax Technologies (DVAX) Maintains Market Outperform Rating | DVAX Stock News - GuruFocus
Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2025 Earnings Call Transcript - Insider Monkey
Dynavax (DVAX) Price Target Reduced, Reports Strong HEPLISAV-B Sales Growth | DVAX Stock News - GuruFocus
Dynavax stock target cut to $31 by Citizens JMP - Investing.com
Dynavax Technologies Corp (DVAX) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
Dynavax Technologies: Q1 Earnings Snapshot - CTPost
Decoding Dynavax Technologies Corp (DVAX): A Strategic SWOT Insi - GuruFocus
Dynavax Technologies Reports Strong Q1 2025 Results - TipRanks
Earnings call transcript: Dynavax Q1 2025 misses EPS forecast, stock dips - Investing.com
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Dynavax Q1 2025 slides: HEPLISAV-B revenue jumps 36%, pipeline advances - Investing.com Canada
Earnings Flash (DVAX) Dynavax Technologies Posts Q1 Revenue $68.2M, vs. FactSet Est of $69.6M - marketscreener.com
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dynavax Technologies Corp Stock (DVAX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):